Gerresheimer AG, a maker of packaging for medicines and cosmetics, said an external investigation it commissioned has found evidence of probable accounting issues from last year and that the probe will continue.
After disagreeing with findings by Germany’s financial watchdog last month, Gerresheimer now says that it is “more likely to assume”that it did indeed fail to properly recognize sales during the 2024 financial year.
An initial external probe by a law firm hired by Gerresheimer centered on roughly €3 million ($3.5 million) in booked revenue from a contract last year, the company said. The law firm will ...
